Dr Mark Aspinall-O’Dea will be presenting during the conference session: “Winning strategies for CAR T, TIL and TCR therapy”. His talk is entitled:
Target specificity screening of CAR T cells using human cell microarray technology
Mark will present case studies demonstrating the utility of the technology in identifying novel, druggable targets as well as in specificity screening for scFvs and CAR T cells to aid safety assessment and provide key data to support IND submissions.
For more information about the event, please visit the PEGS website.